MarketCap
Facebook
X
TelegramAkers Biosciences, Inc. Total Assets 2011-2026 | AKER
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Akers Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 10.9 M | 10.9 M | 7.81 M | 10.9 M | 5.09 M | 8.27 M | 16.7 M | 6.08 M | 6.42 M | 6.88 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.7 M | 5.09 M | 8.98 M |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
20.1 B | $ 16.55 | -0.63 % | $ 8.49 B |  USA |
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
Alcon
ALC
|
31.6 B | $ 74.08 | -0.76 % | $ 40.4 B |  Schweiz |
 |
The Cooper Companies
COO
|
12.4 B | $ 68.85 | -2.06 % | $ 13.7 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
192 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.67 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
18.7 M | $ 6.76 | -4.05 % | $ 57.3 K | USA |
 |
Ekso Bionics Holdings
EKSO
|
20.1 M | $ 9.14 | -6.26 % | $ 22.2 M | USA |
 |
BioLife Solutions
BLFS
|
399 M | $ 18.62 | -3.37 % | $ 858 M | USA |
 |
Glaukos Corporation
GKOS
|
940 M | $ 116.32 | -0.36 % | $ 5.63 B | USA |
 |
AtriCure
ATRC
|
654 M | $ 29.09 | -0.34 % | $ 1.39 B | USA |
 |
Haemonetics Corporation
HAE
|
2.45 B | $ 59.06 | 1.1 % | $ 2.97 B | USA |
 |
Harvard Bioscience
HBIO
|
80.1 M | $ 5.31 | -3.95 % | $ 236 M | USA |
 |
iRhythm Technologies
IRTC
|
1.02 B | $ 116.43 | -0.68 % | $ 3.73 B | USA |
 |
Repro Med Systems
KRMD
|
28.2 M | $ 4.26 | - | $ 197 M | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 178.36 | -0.07 % | $ 9.51 B | USA |
 |
Microbot Medical
MBOT
|
81.5 M | $ 2.29 | -2.97 % | $ 105 M |  Israel |
 |
Milestone Scientific
MLSS
|
7.81 M | $ 0.29 | 1.38 % | $ 23.8 M | USA |
 |
Envista Holdings Corporation
NVST
|
5.68 B | $ 24.99 | -3.21 % | $ 4.2 B | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 50.03 | 3.09 % | $ 164 M | USA |
 |
ResMed
RMD
|
5.1 B | $ 223.41 | -0.62 % | $ 32.6 B | USA |
 |
ICU Medical
ICUI
|
4.05 B | $ 121.46 | -1.24 % | $ 2.99 B | USA |
 |
Retractable Technologies
RVP
|
143 M | $ 0.72 | 1.45 % | $ 21.6 M | USA |
 |
InfuSystem Holdings
INFU
|
99.4 M | $ 9.41 | -0.21 % | $ 194 M | USA |
 |
Isoray
ISR
|
267 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
20.5 B | $ 450.18 | -0.53 % | $ 161 B | USA |
 |
STAAR Surgical Company
STAA
|
452 M | $ 21.38 | 2.0 % | $ 1.06 B | USA |
 |
Stereotaxis
STXS
|
52.3 M | $ 1.86 | -1.59 % | $ 169 M | USA |
 |
LeMaitre Vascular
LMAT
|
616 M | $ 109.87 | 0.65 % | $ 2.49 B | USA |
 |
Teleflex Incorporated
TFX
|
6.95 B | $ 115.67 | 0.51 % | $ 5.16 B | USA |
 |
Merit Medical Systems
MMSI
|
2.69 B | $ 68.33 | 0.77 % | $ 4.04 B | USA |
 |
Utah Medical Products
UTMD
|
123 M | $ 63.75 | 1.3 % | $ 207 M | USA |
 |
Predictive Oncology
POAI
|
52.9 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
94.5 M | $ 19.27 | -16.0 % | $ 1.3 B | USA |
 |
West Pharmaceutical Services
WST
|
4.27 B | $ 257.61 | 0.25 % | $ 18.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.43 B | $ 11.46 | -1.55 % | $ 2.29 B | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
STERIS plc
STE
|
10.1 B | $ 218.23 | -0.8 % | $ 21.5 B | USA |
 |
AngioDynamics
ANGO
|
280 M | $ 9.44 | -4.07 % | $ 386 M | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 154.93 | -0.2 % | $ 44.6 B | USA |
 |
Nephros
NEPH
|
11.9 M | $ 2.73 | -4.55 % | $ 28.4 M | USA |
 |
OraSure Technologies
OSUR
|
403 M | $ 3.03 | -1.79 % | $ 223 M | USA |
 |
Repligen Corporation
RGEN
|
2.83 B | $ 114.82 | -1.82 % | $ 6.4 M | USA |